Eli Lilly said on Friday that its erectile dysfunction drug tadalafil (Cialis) could not be launched immediately in Europe following a switch in manufacturing sites.
The drug, which promises to work faster and last longer than Pfizer’s sildenafil (Viagra) received approval from the European Commission yesterday.
השאירו תגובה
רוצה להצטרף לדיון?תרגישו חופשי לתרום!